针对新兴/重新出现的病毒的saRNA疫苗研究取得了进展
Yalan Liu1,2, Yuncheng Li1,3, Qinxue Hu1,4
1State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
Vaccines
|July 29, 2023
概括
自放大RNA (saRNA) 疫苗为新兴病毒提供了快速的设计和制造. 本综述探讨了saRNA技术,其潜力,以及未来疫苗开发的挑战.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
- 生物技术是生物技术.
背景情况:
- 传统的疫苗面临着对新兴病毒的快速发展的挑战.
- 使者RNA (mRNA) 疫苗提供了一个更快的替代方案,可以在几天内生产.
- mRNA疫苗提供了可扩展性,缺乏整合风险.
研究的目的:
- 提供自我放大RNA (saRNA) 疫苗的概述.
- 讨论saRNA疫苗技术的未来方向和挑战.
- 突出SARNA疫苗对新兴和重新出现的病毒的潜力.
主要方法:
- 审查关于saRNA疫苗技术的现有文献.
- 分析saRNA与非复制mRNA疫苗的优势.
- 讨论saRNA疫苗的可扩展性和制造工艺.
主要成果:
- saRNA疫苗是一种独特的mRNA疫苗类别,具有自我放大能力.
- 该平台允许快速设计和生产,这对抗疫情至关重要.
- 萨RNA疫苗有可能克服传统疫苗方法的局限性.
结论:
- saRNA疫苗代表了对抗新兴/重新出现的病毒威胁的有希望的平台.
- 需要进一步的研究和开发来应对saRNA技术的挑战.
- 萨RNA疫苗的快速反应能力是公共卫生紧急情况的重要优势.
相关概念视频
Viral Mutations
32.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K
Microorganisms in Medicine and Therapeutics
54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
Viruses with RNA Genomes
56
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
56
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K


